Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

ermK Leader Peptide : Amino Acid Sequence Critical for Induction by Erythromycin

  • Kwon, Ae-Ran (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Min, Yu-Hong (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Yoon, Eun-Jeong (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Kim, Jung-A (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Shim, Mi-Ja (Department of Life Sciences, University of Seoul) ;
  • Choi, Eung-Chil (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The ermK gene from Bacillus lichenformis encodes an inducible rRNA methylase that confers resistance to the macrolide-lincosamide-streptogramin B antibiotics. The ermK mRNA leader sequence has a total length of 357 nucleotides and encodes a 14-amino acid leader peptide together with its ribosome binding site. The secondary structure of ermK leader mRNA and a leader peptide sequence have been reported as the elements that control expression. In this study, the contribution of specific leader peptide amino acid residues to induction of ermK was studied using the PCR-based megaprimer mutation method. ermK methylases with altered leader peptide codons were translationally fused to E. coli ${\beta}-galactosidase$ reporter gene. The deletion of the codons for Thr-2 through Ser-4 reduced inducibility by erythromycin, whereas that for Thr-2 and His-3 was not. The replacement of the individual codons for Ser-4, Met-5 and Arg-6 with termination codon led to loss of inducibility, but stop mutation of codon Phe-9 restored inducibility by erythromycin. Collectively, these findings suggest that the codons for residue 4, 5 and 6 comprise the critical region for induction. The stop mutation at Leu-7 expressed constitutively ermK gene. Thus, ribosome stalling at codon 7 appears to be important for ermK induction.

Keywords

References

  1. Choi, S. S., Kim, S. K., Oh, T. G., and Choi, E. C., Role of mRNA termination in regulation of ermK. J. Bacteriol., 179, 2065-2067 (1997) https://doi.org/10.1128/jb.179.6.2065-2067.1997
  2. Dubnau, D., Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics. Crit. Rev. Biochem., 16, 103-132 (1984) https://doi.org/10.3109/10409238409102300
  3. Fang, P., Wang, Z., and Sachs, M. S., Evolutionarily conserved features of the arginine attenuator peptide provide the necessary requirements for its function in translational regulation. J. Biol. Chem., 275, 26710-26719 (2000)
  4. Frank, S., Raz, Z., Jorg, H., Anat, B., Ante, T., Renate, A., Ada, Y., and Francois, F., Structural basis for the interaction of antibiotics with the peptidyl transferase center in eubacteria. Nature, 413, 814-821 (2001) https://doi.org/10.1038/35101544
  5. Hue, K. K. and Bechhofer, D. H., Effect of ermC leader region mutations on induced mRNA stability. J. Bacteriol., 173, 3732-3740 (1991) https://doi.org/10.1128/jb.173.12.3732-3740.1991
  6. Hue, K. K. and Bechhofer, D. H., Regulation of the macrolidelincosamide- streptogramin B resistance gene ermD. J. Bacteriol., 174, 5860-5858 (1992) https://doi.org/10.1128/jb.174.18.5860-5868.1992
  7. Kwak, J. H., Choi, E. C., and Weisblum, B., Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis. J. Bacteriol., 173, 4725-4735 (1991) https://doi.org/10.1128/jb.173.15.4725-4735.1991
  8. Leclercq, R. and Couvalin, P., Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother., 35, 1267-1272 (1991) https://doi.org/10.1128/AAC.35.7.1267
  9. Mayford, M. and Weisblum, B., ermC leader peptide : amino acid sequence critical for induction by translational attenuation. J. Mol. Biol., 206, 69-79 (1989) https://doi.org/10.1016/0022-2836(89)90524-X
  10. Mayford, M. and Weisblum, B., Conformational alterations in the ermC transcript in vivo during induction. EMBO J., 8, 4307-4314 (1989)
  11. Mayford, M. and Weisblum, B., The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J. Bacteriol., 172, 3772-3779 (1990) https://doi.org/10.1128/jb.172.7.3772-3779.1990
  12. Miller, J. H., Experiments in molecular genetics, p. 352-355, cold Spring Harbor Laboratory, Cold Spring harbor, N.Y. (1972)
  13. Roger, E. J., Kim, U. J., Ambulos, N. P. Jr., and Lovett, P. S., Four codons in the cat-86 leader define a chloramphenicolsensitive ribosome stall sequence. J. Bacteriol., 172, 110-115 (1990) https://doi.org/10.1128/jb.172.1.110-115.1990
  14. Sarkar, G. and Sommer, S., The 'megaprimer' method of sitedirected mutagenesis. Biotechniques., 8, 404-407 (1990)
  15. Tenson, T., Xiong, L., Kloss, P., and Mankin, A. S., Erythromycin resistance peptides selected from random peptide libraries. J. Biol. Chem., 272, 17425-17430 (1997) https://doi.org/10.1074/jbc.272.28.17425
  16. Weisblum, B., Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother, 39, 577-585 (1995a) https://doi.org/10.1128/AAC.39.3.577
  17. Weisblum, B., Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother., 39, 797-805 Review (1995b) https://doi.org/10.1128/AAC.39.4.797
  18. Yonath, A., Leonard, K. R., and Wittmann, H. G., A tunnel in the large ribosomal subunit revealed by three-dimensional image reconstrucion. Science, 236, 813-816 (1987) https://doi.org/10.1126/science.3576200